Abstract
This chapter is concerned with those pain-killing drugs (analgesics) that are most likely to be misused, ranging from propoxyphene (Darvon) through the synthetic, opiatelike drugs to the major opiates, including morphine and heroin. The generalizations made here apply to almost all prescription painkillers, with the possible exception of the newer prescription anti-inflammatory medications. The material will also be relevant to the newer opiate-type drugs, including the mixed agonist/antagonist butorphanol (Stadol or Borphanol), which is similar to buprenorphene and nalbuphene, as well as fentanyl (Sublimaze). Most of these newer medications have not yet met the test of time to determine their actual propensity to develop adverse reactions, including addiction.1,2
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Vandam, L. D. Butorphanol. New England Journal of Medicine 302: 381–384, 1980.
Hayes, J. R. Gentanyl. California Society for Treatment of Alcoholism and Other Drug Dependence News 8: 3–5, 1981.
Berridge, V. Opium and the historical perspective. Lancet 2: 78–80, 1977.
Musto, D. F. The American Disease. Origins of Narcotic Control. New Haven, Conn.: Yale University Press, 1973.
Stimmel, B. Heroin Dependency: Medical, Economic, and Social Aspects. New York: Stratton Intercontinental Medical Book Corp., 1975.
Jaffe, J. H., & Martin, W. R. Opioid analgesics and antagonists. In A. F. Gilman, L. S. Goodman, & A. Gilman (Eds.), The Pharmacological Basis of Therapeutics (6th ed.). New York: Macmillan, 1980.
Koob, G. F., & Bloom, F. E. Behavioral effects of opioid peptides. British Medical Bulletin 39: 89–94, 1983.
Marshal, B. E., & Wollman H. General anesthetics. In A. F. Gilman, L. S. Goodman, & A. Gilman (Eds.), The Pharmacological Basis of Therapeutics (6th ed.). New York: Macmillan, 1980.
Cohen, M. R., Cohen, R. M., Pickar, D., et ah Behavioural effects after high dose naloxone administration to normal volunteers. Lancet 2: 1110, 1981.
Bloom, F., Segal, D., Ling, N., et al. Endorphins: Profound behavioral effects in rats suggest new etiological factors in mental illness. Science 194: 630–632, 1976.
Stimmel, B. The socioeconomics of heroin dependency. New England Journal of Medicine 287: 1275–1280, 1972.
Zinberg, N. E., & Jacobson, R. C. The natural history of “chipping. ” American Journal of Psychiatry 133: 37–40, 1976.
Caplovitz, D. The Working Addict. New York: The Graduate School and the University Center of the City University of New York, 1976.
Dess, W. J., & Cole, F. C. The medically evacuated Viet-Nam narcotic abuser: A follow- up rehabilitative study. Bulletin on Narcotics 24: 55–65, 1977.
Robins, L. N., Helzer, J. E., & Davis, D. H. Narcotic use in Southeast Asia and afterward. Archives of General Psychiatry 32: 955–961, 1975.
Wechsler, H., & Rohman, M. E. Patterns of drug use among New England college students. American Journal of Drug and Alcohol Abuse 8: 27–37, 1981.
Des Jarlais, D. C., & Uppal G. S. Heroin activity in New York City, 1970–1978. American Journal of Drug and Alcohol Abuse 7: 335–346, 1980.
Halikas, J. A., Darvish, H. S., & Rimmer, J. D. The black addict: 1. Methodology, chronology of addiction, and overview of the population. American Journal of Drug and Alcohol Abuse 3: 529–543, 1976.
Croughan, J. L., Miller, J. P., Wagelin, D., et al. Psychiatric illness in male and female narcotic addicts. Journal of Psychiatry 43: 225–228, 1982.
Langenauer, B. J., & Bowden, C. L. A follow-up study of narcotic addicts in the NARA program. American Journal of Psychiatry 128: 73–78, 1971.
O’Brien, C. P., Woody, G. E., & McLellan, A. T. Long-term consequences of opiate dependence. The New England Journal of Medicine 304: 1098–1099, 1981.
Vaillant, G. E. A 20-year follow-up of New York narcotic addicts. Archives of General Psychiatry 29: 237–241, 1973.
Snow, M. Maturing out of narcotic addiction in New York City. The International Journal of Addictions 8: 921–938, 1973.
Winick, C. The life cycle of the narcotic addict and of addiction. Bulletin on Narcotics 26:1–11, 1964.
Kandel, D. B. Longitudinal Research on Drug Use. New York: Halstead Press, 1978.
Simpson, D. D., & Lloyd, M. R. Alcohol use following treatment for drug addiction. Journal of Studies on Alcohol 42: 323–335, 1981.
Croughan, J. L., Miller, J. P., Whitman, B. Y., & Schober, J. G. Alcoholism and alcohol dependence in narcotic addicts: A prospective study with a five-year follow-up. American Journal of Drug and Alcohol Abuse 8: 85–94, 1981.
McGlothlin, W. H., & Anglin, M. D. Shutting off methadone, costs and benefits. Archives of General Psychiatry 38: 885–892, 1981.
Lass, H. Most chronic pain patients misuse drugs, study shows. Hospital Tribune World Service 6: 2, 1976.
Jones, R. E. A study of 100 physician psychiatric inpatients. American Journal of Psychiatry 134: 1119–1122, 1977.
Siegel, S., Hirison, R. E., Krank, M. D., & McCully, J. Heroin “overdose” death: Contribution of drug-associated environmental cues. Science 226: 436–437, 1982.
Kaufman, R. E., & Levy, S. B. Overdose treatment. Addict folklore and medical reality. Journal of the American Medical Association 227: 411–413, 1974.
Greene, M. H., & DuPont, R. L. The treatment of acute heroin toxicity. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974.
Dimijian, G. G. Differential diagnosis of emergency drug reactions. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974.
Kleber, H. D. The treatment of acute heroin toxicity. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974.
Oppenheimer, E., Stimson, G. V., & Thorley, A. Seven-year follow-up of heroin addicts: Abstinence and continued use compared. British Medical Journal 2:627–630, 1979.
McLellan, A. T., Woody, G. E., & O’Brien, C. P. Development of psychiatric illness in drug abusers. New England Journal of Medicine 302: 1310–1314, 1979.
Rousaville, B. J., Weissman, M. M., Crits-Christoph, K., Wilbur, C., & Kleber, H. Diagnosis and symptoms of depression in opiate addicts. Archives of General Psychiatry 39: 151–156, 1982.
Dorus, W., & Senay, E. C. Depression, demographics, and drug abuse. American Journal of Psychiatry 237: 699–704, 1980.
Siegel, S. Evidence from rats that morphine tolerance is a learned response. Journal of Comparative Physiology and Psychology 89: 498–506, 1975.
Shapira, J. Drug Abuse: A Guide for the Clinician. New York: American Elsevier, 1975.
Cohen, S. (Ed.). The drug schedules: An updating for professionals. Drug Abuse and Alcoholism Newsletter 5. San Diego: Vista Hill Foundation, Apr. 1976.
Dole, V. P. Management of the opiate abstinence. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974.
Sorenson, J. L., Hargreaves, W. A., & Weinberg, J. A. Withdrawal from heroin in three or six weeks. Archives of General Psychiatry 39: 167–171, 1982.
Tennant, F. S., & Uelmen, G. F. Prescribing narcotics to habitual and addicted narcotic users: Medical and legal guidelines in California and some other western states (medicine and the law). Western Journal of Medicine 233: 539–545, 1980.
Tennant, F. S., Russell, B. A., Casas, S. K., et al. Heroin detoxification. A comparison of propoxyphene and methadone. Journal of the American Medical Association 232: 1019–1022, 1975.
Jasinski, D. R., Pevnick, J. S., Clark, S. C., & Griffith, J. D. Therapeutic usefulness of propoxyphene napsylate in narcotic addiction. Archives of General Psychiatry 34: 227–233, 1977.
Frartz, D. N., Hare, B. D., & McCloskey K. L. Spinal sympathetic neurons: Possible sites of opiate-withdrawal suppression by Clonidine. Science 225: 1643–1645, 1982.
Charney, D. S., Riordan, C. E., Kleber, H. D., et al A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy. Archives of General Psychiatry 39: 1327–1332, 1982.
Gold, M. S., Pottash, A. C., & Kleber, H. D. Outpatient Clonidine detoxification. Lancet 2: 621, 1981.
Charney, D. S., Sternberg, D. E., Kleber, H. D., Heninger, G. R., & Redmond, D. E. The clinical use of Clonidine in abrupt withdrawal from methadone. Archives of General Psychiatry 38: 1273–1277, 1981.
Jasinski, D. R., Johnson, R. E., & Makhxoumi, H. Efficacy of Clonidine in morphine withdrawal. Presented at the 20th Annual ACNP in San Diego, December 16–18, 1981.
Clement-Jones, V., Tomlin, S., Rees, L. H., McLoughlin, L., Besser, G. M., & Wen, H. L. Increased β-endorphin but no metenkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain. Lancet 2: 946–948, 1980.
Sheffet, A., Quinones, M., Levenhar, M. A., et al. An evaluation of detoxification as an initial step in the treatment of heroin addiction. American Journal of Psychiatry 133: 337–340, 1976.
Green, M., & Suffet, F. The neonatal narcotic withdrawal index: A device for the im–provement of care in the abstinence syndrome. American Journal of Drug and Alcohol Abuse 8: 203–213, 1981.
Hoder, E. L., Leckman, J. F., Ehrenkranz, R., Kleber, H., Cohen, D. J., & Poulsen J. A. Clonidine in neonatal narcotic-abstinence syndrome. New England Journal of Medicine 305: 1284, 1981.
Strass, M. E., Andresko, M., Stryker, J. C., et al. Relationship of neonatal withdrawal to maternal methadone dose. American Journal of Drug and Alcohol Abuse 3: 339–345, 1976.
Reddy, A. M. The management of the narcotic withdrawal syndrome in the neonate. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974.
Cherubin, C. E. Management of acute medical complications resulting from heroin addiction. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974.
Wolters, E., Stam, F. C., Lousberg, R. J., et al. Leucoencephalopathy after inhaling “heroin” pyrolysate. Lancet 2: 1233–1238, 1982.
Mendelson, J. H., Mendelson, J. E., & Patch, V. D. Plasma testosterone levels in heroin addiction and during methadone maintenance. The Journal of Pharmacology and Experimental Therapeutics 192: 211–217, 1975.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Schuckit, M.A. (1984). Opiates and Other Analgesics. In: Drug and Alcohol Abuse. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1176-8_6
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1176-8_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1178-2
Online ISBN: 978-1-4684-1176-8
eBook Packages: Springer Book Archive